B7-H3: a robust target for immunotherapy in prostate cancer

Rafael Pulido1, José I López2, Caroline E Nunes-Xavier3

  • 1Biobizkaia Health Research Institute, Barakaldo, Spain; Ikerbasque, Basque Foundation for Science, Bilbao, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain.

Trends in Cancer
|June 5, 2024
PubMed
Abstract

Related Concept Videos